Effects of Theraband Resistance Training on Muscle Strength in Coronary Artery Diseases
Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 27, 2024
Trial Information
Current as of February 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants having a documented diagnosis of CAD, confirmed by a medical professional.
- • Individuals with a history of myocardial infarction (heart attack), angina, or evidence of significant coronary artery stenosis.
- • Stable CAD who were not experiencing acute coronary events, such as recent heart attacks or unstable angina.
- • Patients who were able to perform exercises with TheraBand.
- • Reduced muscle strength of upper limb/lower limb
- Exclusion Criteria:
- • Patients over the age of 75 years.
- • Exclude individuals with a recent history of Theraband resistance training.
- • Severe cardiovascular complications such as heart failure with reduced ejection fraction, severe arrhythmias, or uncontrolled hypertension.
- • Patients with unstable conditions or cardiac episodes.
- • Individuals who had undergone major cardiovascular surgery (e.g., coronary artery bypass grafting) within the last six months.
- • Ejection fraction \< 40%
Trial Officials
Muhammad Iqbal Tariq, PhD*
Principal Investigator
Riphah International University
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0